First filing for FOZNOL* (lanthanum carbonate) in Europe
15-Mar-2001 -
Shire Pharmaceuticals Group plc (Nasdaq: SHPGY, LSE: SHP.L) announces that the first regulatory submission for
Foznol* (lanthanum carbonate, Project Lambda) was delivered to a Reference Member State in the EU Mutual Recognition Procedure yesterday.
Foznol* is being developed for the treatment ...
calcium
cardiovascular diseases
chronic renal failure
+12